Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.
about
Synthetic LXR ligand inhibits the development of atherosclerosis in miceThe retinoid X receptors and their ligandsMicroRNAs in lipid metabolismRegulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sitesCholesterol, inflammation and innate immunityNongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human plateletsIs it time to modify the reverse cholesterol transport model?Cloning of a novel retinoid-inducible serine carboxypeptidase from vascular smooth muscle cellsPDGF-induced proliferation of smooth muscular cells is related to the regulation of CREB phosphorylation and Nur77 expressionGlucose regulates LXRalpha subcellular localization and function in rat pancreatic beta-cellsMacrophage-independent regulation of reverse cholesterol transport by liver X receptors.PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia.Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver.Nuclear receptors, mitochondria and lipid metabolismNitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligandCNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models.Identification of macrophage liver X receptors as inhibitors of atherosclerosis.Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harmLigand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells.Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.Retinaldehyde dehydrogenase 1 deficiency inhibits PPARγ-mediated bone loss and marrow adiposity.Novel agents for managing dyslipidaemia.Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetesIntegrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformationThe phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesionsRegulation and mechanisms of macrophage cholesterol effluxThe macrophage foam cell as a target for therapeutic intervention.RXR activators molecular signalling: involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heartRetinoids: fascinating up-and-coming scenario.PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophagesBexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis.Peroxisome proliferator-activated receptor gamma: the more the merrier?End-stage renal disease--not an equal opportunity disease: the role of genetic polymorphisms.Combinatorial roles of nuclear receptors in inflammation and immunity.The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosisTranscriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases.PPAR Agonists and Cardiovascular Disease in Diabetes.
P2860
Q24530617-C94C2681-16B7-41BD-B25D-2EC60978EFEEQ24562747-1FD8F327-7F26-45E4-9CDE-17E5C0FEB5BDQ24633633-9249AB1F-1B5B-453D-8240-0945912A30C7Q27025972-16A02D33-0200-4E19-9BE6-6F569504E714Q28086912-BEB1CC44-DC8C-46AC-9804-B301F40A553FQ28217479-07ABDBBF-038E-491D-8ABF-A9B8A862A6C1Q28363458-95ACC577-65BC-409A-9562-8C2774FBFD6BQ28565997-3B136D97-C2D6-46FE-B99E-D3BDA441F056Q28575756-42C8C81F-9944-42EE-B9A2-588B587B3BB0Q28579781-DAC432F2-B575-4205-910B-1E9E4E70F158Q30371540-237D302A-5D4B-4275-9BFB-1438F4CD034AQ30484694-49A502DD-778E-4A8E-B8D8-28B474B87FEAQ31144077-D41E3716-36CC-4856-9D04-29D5019FB05CQ33585657-D7DA3481-F9FC-4D19-A7E8-1F6E0C694FD4Q33670343-F4905CA0-94E4-4C9E-980E-8BF0A576D20EQ33699001-6F47CEFA-E5FD-4B66-887C-12B05B2D8559Q33849597-56C4EE4B-E07A-4511-8C41-9D5807BC0E8DQ34067485-E01B7CCD-63C7-486F-82EA-281327D29A81Q34154665-4579C887-0CBA-4A59-9A80-806995F0B19AQ34165847-EB558E2A-9D0D-446A-8A8D-19A78892E546Q34165880-0E95BCEA-D494-482F-AFEC-511A235F56E2Q34277079-7E5B3162-AF7B-408C-AA6D-561B4C3DA429Q34402668-FAD09C41-E787-4283-8D2D-FE5E6643A0D9Q34481800-C9FA68B1-0E6E-435B-91C1-7B4BC955D79AQ34509903-4C5474E8-2D54-4FBD-985F-C30C5A94D1FAQ34549788-15BAEA6C-3389-4BFC-BE59-379B35CFAC2AQ34740387-CE9F0AE1-A840-48D8-A5D2-C6F3413794D4Q34798750-D90D8D55-5623-42DB-93B3-382BB570AD91Q34986351-FECE3E11-1969-42F2-BAC7-62B6573A51D8Q35045046-F4F97B99-D706-4122-B9DF-682C6D1D41C2Q35139681-5C6CB656-FFBA-4E50-AF94-C5F66E659C5AQ35144057-90FA1263-05F0-4A9B-A2D8-6E4D35B56062Q35995939-ACBB233A-7047-4E44-B91F-5390C70AE2CBQ36012843-0134A841-68C6-4A9F-A296-D34F0063FF06Q36018557-79B8B0D7-EBCB-4913-A748-A5FF1C3A84ACQ36161446-3A53AD4F-CDED-4C87-BF5F-3DA03043B64FQ36403404-E1D8E29D-D8DF-4708-B166-55BAB77485AEQ36405110-3574C2E0-8303-4D3E-98ED-549C9885B572Q36426782-F61B49B2-FE83-4D65-B225-8D4D7D13DADBQ36444975-9CC9C8D4-1109-433D-855B-7563AF356114
P2860
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Reduction of atherosclerosis i ...... on of the retinoid X receptor.
@ast
Reduction of atherosclerosis i ...... on of the retinoid X receptor.
@en
Reduction of atherosclerosis i ...... on of the retinoid X receptor.
@nl
type
label
Reduction of atherosclerosis i ...... on of the retinoid X receptor.
@ast
Reduction of atherosclerosis i ...... on of the retinoid X receptor.
@en
Reduction of atherosclerosis i ...... on of the retinoid X receptor.
@nl
prefLabel
Reduction of atherosclerosis i ...... on of the retinoid X receptor.
@ast
Reduction of atherosclerosis i ...... on of the retinoid X receptor.
@en
Reduction of atherosclerosis i ...... on of the retinoid X receptor.
@nl
P2093
P2860
P356
P1476
Reduction of atherosclerosis i ...... ion of the retinoid X receptor
@en
P2093
J M Lobaccaro
J R Paterniti
M D Leibowitz
R A Heyman
P2860
P304
P356
10.1073/PNAS.041609298
P407
P577
2001-02-20T00:00:00Z